Dr. David Stephen Freitag, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Not Enrolled in Medicare Practice Location: 26800 S Tamiami Trl, Suite 360, Bonita Springs, FL 34134 Phone: 239-495-1234 Fax: 239-495-2345 |
Cynthia D Hensley, M.D., P.A. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 26661 Dublin Woods Circle, Bonita Springs, FL 34135 Phone: 239-390-9933 Fax: 239-390-2095 |
John Raymond Marnocha, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3330 Crossings Ct, Ph2, Bonita Springs, FL 34134 Phone: 239-948-9446 Fax: 239-948-9446 |
Brian George Fabian, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 26800 S Tamiami Trl, Suite 310, Bonita Springs, FL 34134 Phone: 239-949-0742 Fax: 239-949-0768 |
Dr. Roxanna Maria Menendez, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 25987 S. Tamiami Trail, Unit 90, Bonita Springs, FL 34134 Phone: 239-444-3201 Fax: 239-992-9359 |
Suzy Lee, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9411 Fountain Medical Ct, Ste E100, Bonita Springs, FL 34135 Phone: 239-221-8516 Fax: 239-221-8787 |
Dr. Sarah Churton, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 23471 Walden Center Drive, Suite 300, Bonita Springs, FL 34134 Phone: 239-596-9337 Fax: 239-596-9466 |
Dr. K. L. Spear, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 8951 Bonita Beach Rd Se, Suit 525 #101, Bonita Springs, FL 34135 Phone: 239-936-5425 |
News Archive
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday posted the results of several internal audits, showing "that 12 more probes had turned up an additional $20 million of mismanagement, alleged fraud and misspending," the Associated Press/CBSNews.com reports.
Unlocking the secrets to better treating the pernicious disorders of obesity and dementia reside in the brain, according to a paper from American University's Center for Behavioral Neuroscience.
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.
Infectious diseases specialists from Austin Health are working closely with Microbiologists from the University of Melbourne to understand how Staph is becoming resistant to all antibiotic therapies.
› Verified 6 days ago